WVE · Categories · Coverage
WVE - Analyst coverage initiated
Wave Life Sciences Ltd. (WVE) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for WVE
- Ladenburg Thalmann initiated coverage on Wave Life Sciences with a new price targetLadenburg Thalmann initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $10.00
- BofA Securities initiated coverage on Wave Life Sciences with a new price targetBofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00
- Wells Fargo initiated coverage on Wave Life Sciences with a new price targetWells Fargo initiated coverage of Wave Life Sciences with a rating of Overweight and set a new price target of $18.00
- Canaccord Genuity initiated coverage on Wave Life Sciences with a new price targetCanaccord Genuity initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $19.00
- Oppenheimer initiated coverage on Wave Life Sciences with a new price targetOppenheimer initiated coverage of Wave Life Sciences with a rating of Outperform and set a new price target of $24.00
- Citigroup initiated coverage on Wave Life Sciences with a new price targetCitigroup initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $16.00
- Cantor Fitzgerald initiated coverage on Wave Life Sciences with a new price targetCantor Fitzgerald initiated coverage of Wave Life Sciences with a rating of Overweight and set a new price target of $10.00
- Wedbush initiated coverage on Wave Life Sciences with a new price targetWedbush initiated coverage of Wave Life Sciences with a rating of Outperform and set a new price target of $18.00
- Jefferies initiated coverage on Wave Life Sciences with a new price targetJefferies initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $26.00
- B. Riley Securities initiated coverage on Wave Life Sciences with a new price targetB. Riley Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $11.00
- JP Morgan initiated coverage on Wave Life Sciences with a new price targetJP Morgan initiated coverage of Wave Life Sciences with a rating of Overweight and set a new price target of $10.00
- Wells Fargo initiated coverage on Wave Life Sciences with a new price targetWells Fargo initiated coverage of Wave Life Sciences with a rating of Overweight and set a new price target of $11.00
- Raymond James initiated coverage on Wave Life Sciences with a new price targetRaymond James initiated coverage of Wave Life Sciences with a rating of Outperform and set a new price target of $7.00